Resisting “Treatment- Resistant” Hypertension
E-Publication E-Publication

Resisting “Treatment- Resistant” Hypertension


The activity is jointly provided by Med-IQ and Dallas Nephrology Associates.

Med-IQ Dallas Nephrology Associates

Released:
12/12/18
Expires:
12/11/19

Maximum Credits:

1.0
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

E-Publication E-Publication
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.
Released:
12/12/18

Expires:
12/11/19

Maximum Credits:
1.0
E-Publication E-Publication
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

Released:
12/12/18
Expires:
12/11/19


Maximum Credits:
1.0


Overview: Cindy L. Corpier, MD, transplant and general nephrologist, discusses the ubiquitous problem of hypertension focusing on the troubling increase in cases of resistant hypertension. A systematic approach to the evaluation of the patient with presumed resistant hypertension is presented along with recommendations on screening for secondary causes. The current state of interventional therapies is also reviewed. This 1 hour activity is intended to assist primary care physicians and specialists in managing this increasingly frequent problem.

CME Information:

Faculty
Cindy L. Corpier, MD
Board Certified in Internal Medicine and Nephrology
Transplant and General Nephrologist at Dallas Nephrology Associates
Dallas, Texas

Activity Planners
Sandra M. Lauriat, MD, FACP
Board Certified Nephrologist
Dallas Nephrology Associates
Dallas, TX
 
Samantha Gordon
CME Specialist
Med-IQ
Baltimore, MD
 
Kathryn Schaefer, MSN, RN, CPHRM
Senior Manager, Accreditation and Compliance
Med-IQ
East Lansing, MI
 
Mollyn Shew
Marketing Coordinator
Dallas Nephrology Associates
Dallas, TX

Target Audience
This activity is intended for internal medicine and primary care physicians, as well as cardiologists, endocrinologists, and geriatricians.

Learning Objectives
Upon completion, participants should be able to:

  • Define resistant hypertension (rHTN)
  • Distinguish apparent rHTN from true rHTN by identifying factors and medications contributing to or exacerbating hypertension
  • Assess for causes of secondary hypertension and choose diagnostic testing for cases with high clinical suspicion
  • Implement pharmacologic management and recommend complementary lifestyle practices
  • Summarize the state of interventional treatments for hypertension

Statement of Need
This activity outlines the how primary care physicians can define and treat resistant hypertension (rHTN). After defining rHTN, apparent rHTN vs true rHTN will be explored. The etiology, evaluation and treatment for secondary hypertension will be reviewed. Finally a summary of the state of interventional treatments for hypertension will be provided.

Primary care physicians and specialists need to understand how to define and treat rHTN in order to provide the best quality of care for patients as well as to improve outcomes.

Joint Providership Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Med-IQ and Dallas Nephrology Associates. Med-IQ is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statements
Med-IQ designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Medium/Method of Participation
This CME activity consists of a 1.0-credit online publication. To receive credit, read the introductory CME material, read the publication, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.

Initial Release Date: December 12, 2018
Expiration Date: December 11, 2019
Estimated Time to Complete This Activity: 1 hour

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation. 
 
Cindy Corpier, MD, has indicated no real or apparent conflicts.

Sandra M. Lauriat, MD, FACP, has indicated no real or apparent conflicts.

The peer reviewers and activity planners have no financial relationships to disclose.

Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
 
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.

Contact Information
For questions or comments about this activity, please contact Med-IQ.
Call (toll-free) 866 858 7434 or email info@med-iq.com.

Hardware/Software Requirements
Operating System
Microsoft Windows® 8, Windows 7
Mac OS 10.7 (Lion) or newer

Browser
Microsoft Internet Explorer 8.0 or later

Mozilla Firefox - latest version
Download: http://www.mozilla.org/en-US/firefox/new/

Google Chrome - latest version
Download: http://www.google.com/chrome

Apple Safari - latest version
Download: http://www.apple.com/safari/download/

PDF Viewer
Adobe Acrobat Reader® or Adobe Reader
Download: http://get.adobe.com/reader/

Adobe Flash Player
Adobe Flash Player 9 or later
Download: http://get.adobe.com/flashplayer/

For technical support, go to https://www.med-iq.com/support-manual.html.

ADA Statement
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.

Disclaimer
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
We are committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about Med IQ’s privacy policy, please visit: https://www.Med-IQ.com/privacy-statement/.

Copyright
© 2018 Dallas Nephrology Associates

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email info@med-iq.com. For technical assistance, please refer to our support manual.

We recently updated our Privacy Notice and Terms of Use.